| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3190603 | Annals of Allergy, Asthma & Immunology | 2016 | 5 Pages |
Abstract
Two major endotypes for asthma have been described, TH2-high, manifested by increased eosinophils in the sputum and airways of patients, and TH2-low, with increased neutrophils or a pauci-granulocytic profile. Using these classifications and specific biomarkers has led to promising new therapeutics, especially for TH2-high asthma.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Jeffrey R. MD, Thomas B. MD,